ISRG vs. MDLN: Intuitive Surgical vs. Medline Stock Comparison

Company Profile

Intuitive Surgical (ISRG) and Medline (MDLN) both belong to the Health Care Equipment & Supplies industry, though ISRG is classified under Health Care Equipment while MDLN falls under Health Care Supplies.

Intuitive Surgical (ISRG) has been public since June 16, 2000, giving it decades of market history across multiple cycles, while Medline (MDLN) listed only on December 17, 2025 and lacks comparable through-cycle data.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Medline (MDLN) reports a negative beta of -0.93, suggesting inverse market sensitivity over the measurement window. That is uncommon for ordinary equities and can reflect commodity-linked or hedge-like exposure, but it can also come from statistical noise. Intuitive Surgical (ISRG) has a non-negative beta of 1.41.

Risk-Adjusted Performance

Risk-Return Positioning

Both ISRG and MDLN need 1-year volatility and 1-year return to plot risk-return positioning.

Risk-Adjusted Metrics

Profitability

Intuitive Surgical (ISRG) at 17.93% sits in the top ROE quartile, while Medline (MDLN) at 4.85% is closer to the peer norm — stronger capital efficiency for ISRG.

Intuitive Surgical (ISRG) at 25.54% retains a top-quartile share of revenue as profit, ahead of Medline (MDLN) at 1.85%, which keeps about the industry-typical share.

Intuitive Surgical (ISRG) at 33.29% operates in the top operating margin quartile, ahead of Medline (MDLN) at 5.22%, which runs around its industry’s norm.

Profitability Metrics

Growth

Only one side can be read here: Intuitive Surgical (ISRG) reports revenue growth of 20.51%, ranked against its industry; Medline (MDLN) has no revenue growth figure this period.

Medline (MDLN) at 117.38% clears its industry range for EPS growth, a much stronger earnings trajectory than Intuitive Surgical (ISRG) at 22.59%, which is closer to a typical peer reading.

Growth Metrics

Financial Strength

Intuitive Surgical (ISRG) at 3.33 keeps current ratio within its industry’s typical mid-range, while Medline (MDLN) at 4.04 sits above its industry’s typical mid-range — comfortable liquidity, though possibly with more idle current assets relative to peers.

Only one side’s leverage can be read here: Medline (MDLN) carries debt-to-equity ratio of 0.65 against its industry range, while Intuitive Surgical (ISRG) reports no figure this period.

Financial Strength Metrics

Dividends

Neither Intuitive Surgical (ISRG) nor Medline (MDLN) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Neither Intuitive Surgical (ISRG) nor Medline (MDLN) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Dividend Metrics

Valuation

Both look expensive on trailing earnings: Intuitive Surgical (ISRG) at 54.75 sits in the richer P/E ratio quartile, and Medline (MDLN) at 90.09 is richer still, above its industry range.

Medline (MDLN) at 1.70 prices around its industry’s typical P/S ratio, while Intuitive Surgical (ISRG) at 13.82 clears its benchmark range — ISRG looks notably rich on sales.

Medline (MDLN) at 2.95 is valued about in line with its industry on P/B ratio, while Intuitive Surgical (ISRG) at 9.82 carries an above-peer premium to book — ISRG is pricier on assets.

Valuation Metrics